NCT03775850 A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors Status COMPLETED Phase PHASE1
NCT03768570 Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03762161 A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer Status UNKNOWN Phase PHASE2
NCT03756207 Multidisciplinary Bladder-preservation Therapy for Bladder Cancer Status UNKNOWN Phase NA
NCT03740256 Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors Status RECRUITING Phase PHASE1
NCT03739177 Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients Status UNKNOWN Phase N/A
NCT03718741 Prospective Study of Adjuvant Radiotherapy in High Risk Bladder Cancer. Status TERMINATED Phase NA
NCT03715660 Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study Status COMPLETED Phase NA
NCT03697850 Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03693014 A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03689478 Use of Immediate Hyperthermic Intravesical Chemotherapy Following TURBT Status COMPLETED Phase NA
NCT03664869 Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer Status RECRUITING Phase PHASE3
NCT03662204 Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors Status COMPLETED Phase N/A
NCT03652298 Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners Status TERMINATED Phase PHASE2